Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting lipoxygenases with care.

Patricia M de Souza1, Justine Newson, Derek W Gilroy

  • 1Airway Disease Section, National Heart & Lung Institute, Imperial College of Medicine, Dovehouse Street, London, SW3 6LY, United Kingdom.

Chemistry & Biology
|November 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

L-Glutamine attenuates peritoneal fibrosis developed in 5-Fluorouracil-treated mice.

Experimental biology and medicine (Maywood, N.J.)·2026
Same author

POLB 001, a p38 MAPK inhibitor, decreases local and systemic inflammatory responses following <i>in vivo</i> LPS administration in healthy volunteers: a randomised, double-blind, placebo-controlled study.

Frontiers in immunology·2026
Same author

Challenges of monocyte HLA-DR targeted immunomodulation in sepsis-a prospective observational cohort study.

Frontiers in immunology·2026
Same author

Epoxy-oxylipins direct monocyte fate in inflammatory resolution in humans.

Nature communications·2026
Same author

Review of methodology and re-analysis of lipidomic data focusing on specialised pro-resolution lipid mediators (SPMs) in a human model of resolving inflammation.

International journal of experimental pathology·2024
Same author

The lifespan and kinetics of human dendritic cell subsets and their precursors in health and inflammation.

The Journal of experimental medicine·2024
Same journal

The Hedgehog Pathway Effector Smoothened Exhibits Signaling Competency in the Absence of Ciliary Accumulation.

Chemistry & biology·2017
Same journal

DIVERSE System: De Novo Creation of Peptide Tags for Non-enzymatic Covalent Labeling by In Vitro Evolution for Protein Imaging Inside Living Cells.

Chemistry & biology·2015
Same journal

Differential Regulation of Specific Sphingolipids in Colon Cancer Cells during Staurosporine-Induced Apoptosis.

Chemistry & biology·2015
Same journal

Synthetic Peptides as cGMP-Independent Activators of cGMP-Dependent Protein Kinase Iα.

Chemistry & biology·2015
Same journal

Unraveling the B. pseudomallei Heptokinase WcbL: From Structure to Drug Discovery.

Chemistry & biology·2015
Same journal

Vitamin C as Cancer Destroyer, Investigating Sulfhydration, and the Variability in CFTR Interactome.

Chemistry & biology·2015
See all related articles

Researchers discovered a new metabolite of eicosapentanoic acid, resolvin E2, offering insights into the molecular mechanisms behind fish oil

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Fish oils are known for cardio-protective, anti-inflammatory, and anti-cancer effects.
  • The precise molecular and biochemical mechanisms underlying these benefits remain largely unelucidated.

Purpose of the Study:

  • To identify novel metabolites of eicosapentanoic acid.
  • To elucidate the biochemical pathways involved in fish oil's beneficial properties.

Main Methods:

  • Utilized 5-lipoxygenase pathway analysis.
  • Investigated the metabolic products of eicosapentanoic acid.

Main Results:

  • Identified a new metabolite, resolvin E2, derived from eicosapentanoic acid.
  • Demonstrated the production of resolvin E2 via 5-lipoxygenase.

Related Experiment Videos

Conclusions:

  • Resolvin E2 is a newly identified metabolite of eicosapentanoic acid.
  • This discovery provides a potential molecular target for understanding fish oil's health benefits.